MMS Holdings Inc

Associate Sponsor

MMS is an award-winning, data focused CRO, supporting pharmaceutical and biotech sponsors across the clinical development lifecycle. Founded in 2006 and winner of 2025 Fierce CRO Excellence in Client Service and Partnership Award, MMS is a global team of over 1,000 experts across 4 continents. We translate complex regulatory requirements into clear pathways that accelerate timelines and de-risk development programs. MMS brings end-to-end capabilities across biometrics, regulatory, writing, safety, and data science, enabling sponsors to move from study design through execution to submission with consistency and confidence.

Our Approach:

• Regulatory-first mindset: We plan submissions and downstream requirements from the start, minimizing rework and ensuring clarity.
• Planning guidance: We ensure your clinical development plans and pivotal studies are developed with a global submission target or next label expansion in mind.
• Data-focused: We turn risks into opportunities, enable faster decisions, and build regulatory clarity from the outset, treating data as a strategic asset.
• Innovative AI-enabled technology platforms:
  • Datacise® for advanced real-time analytics and trial optimization.
  • KerusCloud® for simulation-based study design.
  • End-to-end REMS technology for seamless safety program execution
• Long-term continuity: With less than 5% global staff turnover, our teams operate as true extensions of sponsor organizations.

website